Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-07-26
2009-12-29
Mosher, Mary E (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S300000, C530S387100, C436S501000
Reexamination Certificate
active
07638284
ABSTRACT:
The invention provides an isolated and purified nucleic acid molecule encoding mammalian immunoglobulin A inducing protein (IGIP), and methods of using the IGIP nucleic acid molecule and IGIP, e.g., to prepare antibodies. Also provided is an anti-IGIP antibody and uses therefor.
REFERENCES:
patent: 5888799 (1999-03-01), Curtiss, III
patent: 6410508 (2002-06-01), Isales et al.
patent: 6930167 (2005-08-01), Estes et al.
patent: 2007/0042945 (2007-02-01), Bodary et al.
patent: 471453 (1992-02-01), None
Austin et al.J Immunology 2003, vol. 171, pp. 1336-1342.
“U.S. Appl. No. 09/999,256 Final Office Action mailed Sep. 24, 2003”, 12 pgs.
“U.S. Appl. No. 09/999,256 Non-Final Office Action mailed Jan. 14, 2003”, 7 pgs.
“U.S. Appl. No. 09/999,256 Non-Final Office Action mailed Apr. 6, 2004”, 15 pgs.
“U.S. Appl. No. 09/999,256 Notice of Allowance mailed Dec. 29, 2004”, 6 pgs.
“U.S. Appl. No. 09/999,256 Response to Final Office Action filed Jan. 22, 2004”, 9 pgs.
“U.S. Appl. No. 09/999,256 Response to Non-Final Office Action filed Apr. 14, 2003”, 8 pgs.
“U.S. Appl. No. 09/999,256 Response to Non-Final Office Action filed Jul. 27, 2004”, 9 pgs.
“International Application No. PCT/US01/45021 International Search Report mailed Apr. 3, 2003”, 9 pgs.
Asanuma, H. , et al., “Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine”,Vaccine, 19, (2001),Abstract.
Austin, A. , et al., “Identification and Characterization of a Novel Regulatory Factor: IgA-Inducing Protein”,Journal of Immunology, 171(3), (Aug. 1, 2003),1336-1342.
Denny, S. L., et al., “Antigen-specific humoral immune responses to a hapten-carrier conjugate in SCID mice engrafted with bovine fetal hematopoietic tissues”,Lab Anim. Sci., 46, (1996),Abstract.
Haas, K. M., et al., “Enhancing effects of anti-CD40 treatment on the immune response of SCID-bovine mice to Trypanosoma congolense infection”,J. Leukoc. Biol., 70, (2001),Abstract.
Nobiron, I. , et al., “Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice”,Vaccine, 19, (2001),Abstract.
Operschall, E. , et al., “Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice”,J. Clin. Virol., 13, (1999),Abstract.
EMBL/GenBank/DDBJ Databases, Genetic Sequence Listing, Accession No. AC011379,(Oct. 7, 1999), 42 p.
EMBL/GenBank/DDBJ Databases, Genetic Sequence Listing, Accession No. AF173827,(Sep. 29, 2000), 1 p.
Genbank Accession # BF713462, sequence comparison sheet.
Austin, A. , et al., “Characterization of a novel peptide, IGIP, which enhances IgA secretion by bovine B cells”,CRWAD Meeting, Abstract, (Nov. 7-9, 1999), 141.
Brandtzaeg, P. , et al., “Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes”,Gastroenterology. 97(6), (1989), 1562-1584.
Clemons, Donna J., et al., “Evaluation of a subcutaneously implanted chamber for antibody production in rabbits.”,Laboratory Animal Science. 42(3), (1992), 307-311.
Ehrhardt, Rolf O., et al., “Reciprocal regulation of mucosal surface IgA+ B cells by Ig receptor cross-linking and CD40 ligand.”,Journal of Immunology. 157(4), (1996), 1397-1405.
Estes, D. M., et al., “Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression.”,Immunology. 95(4), (1998), 604-611.
Jameson, Bradford A., et al., “A Rationally Designed CD4 Analogue Inhibits Experimental Allergic Encephalomyelitis”,Letters to Nature, 368, (Apr. 21, 1994), 744-746.
Kehrl, John H., et al., “Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.”,Journal of Immunology137(12), (1986), 3855-3860.
Kimmerly, W. , et al.,Genbank(NCBI), (Sep. 1, 1998), Accession # AC005575.
Lebman, D. A., et al., “The Role of TGF-(beta) in Growth, Differentiation, and Maturation of B Lymphocytes”,Microbes and Infection, 1, (1999), 1297-1304.
Marra, et al.,Genbank(NCBI), Accession # AA204132.
Westbrook, C. A.,Human Genome News, 11, (1990), 2(4).
Zan, H. , et al., “CD40 Engagement Triggers Switching to IgA1 and IgA2 in Human B Cells Through Induction of Endogenous TGF-(beta): Evidence for TGF-(beta) But Not IL-10-Dependent Direct S(mu) >> S(alpha) and Sequential S(mu)>>(gamma)>>S(alpha) DNA Recombination”.The Journal of Immunology, 161, (Nov. 15, 1998), 5217-5225.
Estes D. Mark
Haas Karen
Umbright Amy
Board of Regents of the University of Texas
Hill Myron G
Mosher Mary E
Schwegman Lundberg & Woessner, P.A.
The Curators of the University of Missouri
LandOfFree
Immunoglobulin A inducing protein and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoglobulin A inducing protein and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoglobulin A inducing protein and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4106441